CORRESP 1 filename1.htm


August 11, 2020




Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549


Re: IVERIC bio, Inc.
  Registration Statement on Form S-3
  File No. 333-241714
  Request for Acceleration


Ladies and Gentlemen:


Pursuant to Rule 461 under the Securities Act of 1933, as amended, IVERIC bio, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-241714), so that it may become effective at 4:30 p.m., Eastern time, on August 13, 2020, or as soon as practicable thereafter.


Very truly yours,
By: /s/ Todd D.C. Anderman  

Todd D.C. Anderman

Vice President, General Counsel & Corporate Secretary